Steininger P, Bobinger T, Dietrich W, Lee DH, Knott M, Bogdan C, Korn K, Lang R (2017)
Publication Type: Journal article
Publication year: 2017
Book Volume: 4
Pages Range: -
Journal Issue: 4
Rituximab (RTX) has become a standard therapy for certain B cell malignancies and autoimmune diseases. We report 2 RTX-treated patients who developed severe tick-borne encephalitis virus (TBEV) infection. The inability to generate new antibody responses renders RTX-treated patients susceptible to TBEV, impedes laboratory diagnosis, and necessitates preventive vaccination in endemic areas.
APA:
Steininger, P., Bobinger, T., Dietrich, W., Lee, D.-H., Knott, M., Bogdan, C.,... Lang, R. (2017). Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention. Open Forum Infectious Diseases, 4(4), -.
MLA:
Steininger, Philipp, et al. "Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention." Open Forum Infectious Diseases 4.4 (2017): -.
BibTeX: Download